SelectQuote Revenue Soars 55 Percent

SelectQuote (NYSE:SLQT) reported fourth-quarter and full-year 2025 earnings on August 21, 2025, and adjusted EBITDA of $126 million with an 8% margin. Management emphasized rapid growth in healthcare services, operational efficiency gains in its Medicare segment, and a strategic focus on balancing growth with sustainable, cash-generative operations heading into the next fiscal year.Healthcare services (primarily SelectRx) achieved revenue of $743 million, growing 55% year-over-year, while membership increased approximately 31%, highlighting strong operating leverage. SelectRx’s new state-of-the-art Kansas facility has expanded capacity for further growth, and healthcare services delivered $25 million in adjusted EBITDA, up materially year-over-year but still representing a modest segment margin.Accelerating margin expansion and rising adjusted EBITDA in healthcare services suggest SelectQuote's technology-enabled platform is gaining scale advantages, providing a foundation for enhanced cash flow generation and future shareholder returns.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool